Published in Breast Cancer Res Treat on October 01, 1990
Nutrition and survival after the diagnosis of breast cancer: a review of the evidence. J Clin Oncol (2002) 3.16
Obesity and cancer. Oncologist (2010) 3.01
Adiposity and sex hormones in postmenopausal breast cancer survivors. J Clin Oncol (2003) 2.65
Obesity, tamoxifen use, and outcomes in women with estrogen receptor-positive early-stage breast cancer. J Natl Cancer Inst (2003) 2.11
Epidemiologic and molecular risk factors for contralateral breast cancer among young women. Br J Cancer (2003) 1.37
Exercise activity, body size and premenopausal breast cancer survival. Br J Cancer (2004) 1.23
Pre-diagnosis body mass index and survival after breast cancer in the After Breast Cancer Pooling Project. Breast Cancer Res Treat (2011) 1.21
Obesity, diabetes, and survival outcomes in a large cohort of early-stage breast cancer patients. Ann Oncol (2013) 1.18
Examining the influence of beta blockers and ACE inhibitors on the risk for breast cancer recurrence: results from the LACE cohort. Breast Cancer Res Treat (2011) 1.15
Diabetes and prognosis in a breast cancer cohort. J Cancer Res Clin Oncol (2010) 1.14
Body mass index, tumor characteristics, and prognosis following diagnosis of early-stage breast cancer in a mammographically screened population. Cancer Causes Control (2012) 1.05
The California Breast Cancer Survivorship Consortium (CBCSC): prognostic factors associated with racial/ethnic differences in breast cancer survival. Cancer Causes Control (2013) 0.99
The role of SRC-3 in human breast cancer. Nat Rev Clin Oncol (2009) 0.95
Effect of dietary patterns differing in carbohydrate and fat content on blood lipid and glucose profiles based on weight-loss success of breast-cancer survivors. Breast Cancer Res (2012) 0.94
Factors associated with cancer-related fatigue in breast cancer patients undergoing endocrine therapy in an urban setting: a cross-sectional study. BMC Cancer (2010) 0.89
Spore Powder of Ganoderma lucidum Improves Cancer-Related Fatigue in Breast Cancer Patients Undergoing Endocrine Therapy: A Pilot Clinical Trial. Evid Based Complement Alternat Med (2011) 0.87
Effect of a low fat versus a low carbohydrate weight loss dietary intervention on biomarkers of long term survival in breast cancer patients ('CHOICE'): study protocol. BMC Cancer (2011) 0.86
Social class and weight as prognostic factors in early breast cancer. Br J Cancer (1997) 0.85
Association of high obesity with PAM50 breast cancer intrinsic subtypes and gene expression. BMC Cancer (2015) 0.83
BMI influences prognosis following surgery and adjuvant chemotherapy for lymph node positive breast cancer. Breast J (2008) 0.79
Biomarkers of the metabolic syndrome and breast cancer prognosis. Cancers (Basel) (2010) 0.78
Obesity and HER 2 overexpression: a common factor for poor prognosis of breast cancer. Int Semin Surg Oncol (2008) 0.77
Exercise after breast cancer treatment: current perspectives. Breast Cancer (Dove Med Press) (2015) 0.77
The feasibility and acceptability of a diet and exercise trial in overweight and obese black breast cancer survivors: The Stepping STONE study. Contemp Clin Trials (2015) 0.77
Body mass index is not associated with treatment outcomes of breast cancer patients receiving neoadjuvant chemotherapy: korean data. J Breast Cancer (2012) 0.76
The Effect of Patient and Contextual Characteristics on Racial/Ethnic Disparity in Breast Cancer Mortality. Cancer Epidemiol Biomarkers Prev (2016) 0.76
Availability and utility of body mass index for population-based cancer surveillance. Cancer Causes Control (2007) 0.75
Effects of lifestyle modification after breast cancer treatment: a systematic review protocol. Syst Rev (2014) 0.75
The quantitative analysis of mammographic densities. Phys Med Biol (1994) 5.71
A randomized trial of two dose levels of cyclophosphamide, methotrexate, and fluorouracil chemotherapy for patients with metastatic breast cancer. J Clin Oncol (1988) 2.37
Growth factors and stromal matrix proteins associated with mammographic densities. Cancer Epidemiol Biomarkers Prev (2001) 2.35
Case-control study of factors associated with failure to detect breast cancer by mammography. J Natl Cancer Inst (1992) 2.31
The development of a method for assessing the quality of life of cancer patients. Br J Cancer (1984) 2.23
The review of randomization in the Canadian National Breast Screening Study. Is the debate over? CMAJ (1997) 2.07
Symmetry of projection in the quantitative analysis of mammographic images. Eur J Cancer Prev (1996) 2.00
Mammographic parenchymal patterns: a marker of breast cancer risk. Epidemiol Rev (1993) 1.97
Mammographic density, lobular involution, and risk of breast cancer. Br J Cancer (2008) 1.83
Analysis of mammographic density and breast cancer risk from digitized mammograms. Radiographics (1999) 1.77
Automated analysis of mammographic densities. Phys Med Biol (1996) 1.74
The risk of breast cancer associated with mammographic parenchymal patterns: a meta-analysis of the published literature to examine the effect of method of classification. Cancer Detect Prev (1992) 1.67
Critical appraisal of the evidence that dietary fat intake is related to breast cancer risk in humans. J Natl Cancer Inst (1987) 1.52
The measurement of patients' values in medicine. Med Decis Making (1982) 1.44
Body weight and prognosis in breast cancer. J Natl Cancer Inst (1981) 1.44
Quantitative correlation of breast tissue parameters using magnetic resonance and X-ray mammography. Br J Cancer (1996) 1.43
Fish consumption and breast cancer risk: an ecological study. Nutr Cancer (1989) 1.38
Automated analysis of mammographic densities and breast carcinoma risk. Cancer (1997) 1.38
Scientific problems in clinical scales, as demonstrated in the Karnofsky index of performance status. J Chronic Dis (1979) 1.34
The frequency of malignant neoplasms in patients with polymyositis-dermatomyositis. A controlled study. Arch Intern Med (1985) 1.28
Mammographic signs as risk factors for breast cancer. Br J Cancer (1982) 1.28
Breast cancer risk and measured mammographic density. Eur J Cancer Prev (1998) 1.26
Eliciting preferences for alternative cancer drug treatments. The influence of framing, medium, and rater variables. Med Decis Making (1985) 1.24
Macronutrient intake and change in mammographic density at menopause: results from a randomized trial. Cancer Epidemiol Biomarkers Prev (1999) 1.24
Ratings of the importance of quality of life variables: therapeutic implications for patients with metastatic breast cancer. J Clin Epidemiol (1990) 1.23
Eliciting preferences for alternative drug therapies in oncology: influence of treatment outcome description, elicitation technique and treatment experience on preferences. J Chronic Dis (1987) 1.21
Weight gain in women with localized breast cancer--a descriptive study. Breast Cancer Res Treat (1988) 1.20
Mammographic parenchymal pattern and breast cancer risk: a critical appraisal of the evidence. Am J Epidemiol (1988) 1.19
Comparison of energy intakes determined by food records and doubly labeled water in women participating in a dietary-intervention trial. Am J Clin Nutr (1996) 1.15
Describing health states. Methodologic issues in obtaining values for health states. Med Care (1984) 1.13
Weight gain during adjuvant chemotherapy for breast cancer. Breast Cancer Res Treat (1985) 1.11
Adiposity changes after a 1-year aerobic exercise intervention among postmenopausal women: a randomized controlled trial. Int J Obes (Lond) (2010) 1.07
Attitudes toward quality of survival. The concept of "maximal endurable time". Med Decis Making (1982) 1.04
Atypical hyperplasia and breast cancer risk: a critique. Cancer Causes Control (1992) 1.03
The detection of change in mammographic density. Cancer Epidemiol Biomarkers Prev (2003) 1.03
Observer variation in the classification of mammographic parenchymal patterns. J Chronic Dis (1986) 1.01
Quantitative evaluation of mammographic densities: a comparison of methods of assessment. Eur J Cancer Prev (1995) 1.00
A randomized trial of the total design method for the postal follow-up of women in a cancer prevention trial. Eur J Cancer Prev (1996) 0.99
Quantitative magnetic resonance imaging parameters and their relationship to mammographic pattern. J Natl Cancer Inst (1992) 0.94
A critical appraisal of the Canadian National Breast Cancer Screening Study. Radiology (1993) 0.91
The association of histological and radiological indicators of breast cancer risk. Br J Cancer (1988) 0.90
Bias and the association of mammographic parenchymal patterns with breast cancer. Br J Cancer (1982) 0.88
Mammographic signs of potential relevance to breast cancer risk: the agreement of radiologists' classification. Eur J Cancer Prev (1996) 0.88
Individual and family characteristics associated with protein truncating BRCA1 and BRCA2 mutations in an Ontario population based series from the Cooperative Family Registry for Breast Cancer Studies. J Med Genet (2003) 0.86
The feasibility of testing experimentally the dietary fat-breast cancer hypothesis. Br J Cancer (1990) 0.86
The Cooperative Familial Registry for Breast Cancer Studies: design and first year recruitment rates in Ontario. J Clin Epidemiol (2001) 0.85
Observer variation in the interpretation of xeromammograms. J Natl Cancer Inst (1982) 0.84
Quality of life measurement in breast cancer patients. Br J Cancer (1985) 0.84
Measurement of values for states of health with linear analog scales. Med Decis Making (1983) 0.84
A review of the methods used by studies of dietary measurement. J Clin Epidemiol (1989) 0.84
Ultrasonographically defined parenchymal patterns of the breast: relationship to mammographic patterns and other risk factors for breast cancer. Br J Radiol (1988) 0.83
A study of diet and breast cancer prevention in Canada: why healthy women participate in controlled trials. Cancer Causes Control (1993) 0.82
Mammographic patterns and breast cancer risk: methodologic standards and contradictory results. J Natl Cancer Inst (1984) 0.82
Linear analogue self-assessment of voice quality in laryngeal cancer. J Chronic Dis (1984) 0.82
Bilateral symmetry of breast tissue composition by magnetic resonance in young women and adults. Cancer Causes Control (2014) 0.81
Prospective evaluation of physical examination of the breast. Am J Surg (1981) 0.81
Cyclical mastopathy and premenopausal breast cancer risk. Results of a case-control study. Breast Cancer Res Treat (1995) 0.80
Parenchymal patterns of the breast defined by real time ultrasound. Eur J Cancer Prev (1995) 0.80
Elevated levels of plasma triglycerides are associated with histologically defined premenopausal breast cancer risk. Nutr Cancer (1997) 0.80
New Ontario familial breast cancer registry to facilitate genetic and epidemiologic studies. Can Fam Physician (1997) 0.80
Mammographic patterns and bias in breast cancer detection. Radiology (1982) 0.79
Canadian recommended nutrient intakes underestimate true energy requirements in middle-aged women. Can J Public Health (1998) 0.78
An assessment of the influence of clinical breast examination reports on the interpretation of mammograms in a breast screening program. Ontario Breast Screening Program Radiologists Research Group. Breast Cancer Res Treat (1998) 0.77
Symptoms as an index of growth rates and prognosis in Hodgkin's disease. Clin Invest Med (1978) 0.77
Nutrition and breast cancer. J Natl Cancer Inst (1993) 0.77
Methodological issues in clinical trials of dietary fat reduction in patients with breast dysplasia. Prog Clin Biol Res (1986) 0.75
Attempted abortion by the use of bishydroxycoumarin. Can Med Assoc J (1972) 0.75
Clinical estimation of the growth rate of breast cancer. Cancer (1981) 0.75
Observer variation in the assessment of patients with rectal cancer. Dis Colon Rectum (1982) 0.75
A comparison of the epidemiology of atypical hyperplasia of the breast epithelium and mammographic parenchymal densities. Eur J Cancer Prev (1993) 0.75
Diet and cyclical mastopathy. Lancet (1988) 0.75
Cyclical mastopathy: a critical review of therapy. Br J Surg (1988) 0.75
Feasibility of obtaining breast epithelial cells from healthy women for studies of cellular proliferation. Breast Cancer Res Treat (1997) 0.75
QOL measurement in lung cancer. Pharmacoeconomics (1993) 0.75
Cyclical mastopathy: an evaluation of methods of assessment. J Clin Epidemiol (1989) 0.75
Do patients and physicians agree on the assessment of voice quality in laryngeal cancer? J Otolaryngol (1984) 0.75
The assessment of values in laryngeal cancer: reliability of measurement methods. J Chronic Dis (1984) 0.75
Self-reported physical and emotional health of women in a low-fat, high-carbohydrate dietary trial (Canada). Cancer Causes Control (1998) 0.75
A method of clinical prognostic staging for patients with rectal cancer. Dis Colon Rectum (1983) 0.75
Assessment of a food frequency questionnaire as a screening tool for low fat intakes. Control Clin Trials (1997) 0.75
Economic factors in cancer palliation--methodologic considerations. Cancer Treat Rev (1993) 0.75
Computed tomography in advanced ovarian cancer. Inter- and intraobserver reliability. Invest Radiol (1986) 0.75
Computed tomography in advanced ovarian cancer: an evaluation of diagnostic accuracy. Am J Med Sci (1987) 0.75
Ten-year analysis of the NSABP B-50 study. J Clin Oncol (1986) 0.75
Pretherapeutic morbidity in the prognostic staging of acute leukemia. Arch Intern Med (1979) 0.75
Pretreatment clinical morbidity as an index of the biologic potential of acute lymphoblastic leukaemia of childhood. Leuk Res (1981) 0.75
Serum leptin levels and energy expenditure in normal weight women. Can J Physiol Pharmacol (1998) 0.75
Letter: Mortality and anaemia in women. Lancet (1974) 0.75